CN Stock MarketDetailed Quotes

600351 Yabao Pharmaceutical Group

Watchlist
  • 5.25
  • -0.02-0.38%
Not Open Sep 13 15:00 CST
3.78BMarket Cap17.86P/E (TTM)

Yabao Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Yabao Pharmaceutical Group Q2 2024 Earnings Date

Currency：CNYAug 15, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
672.47M
--
-8.17%
Net Income
--
65.42M
--
+12.67%
Analyst Rating
Strong Buy

Sep 17, 2024

Yabao Pharmaceutical Group Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Apr 24, 20192019/Q1821.494M / 753.000M--
DatePeriodRevenue/EstimateEarnings Call
Apr 24, 20192019/Q1821.494M / 753.000M--

Yabao Pharmaceutical Group Earnings Reports

  • Yabao Pharmaceutical Group Co., Ltd. 2024 Semi-annual Report

    Aug 15 00:00

  • Summary of the 2024 interim report of Yabao Pharmaceutical Group Co., Ltd.

    Aug 15 00:00

  • Yabao Pharmaceutical Group Co., Ltd. Report for the first quarter of 2024

    Apr 26 00:00

  • Summary of the 2023 Annual Report of Yabao Pharmaceutical Group Co., Ltd.

    Apr 26 00:00

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 17, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data